Stocks
Baxter International Financial Statements (BAX) |
||||||||||
| Baxter Internationalsmart-lab.ru | % | 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | |||
|---|---|---|---|---|---|---|---|---|---|---|
| Report date | 17.03.2020 | 11.02.2021 | 23.02.2022 | 09.02.2023 | 08.02.2024 | 08.02.2024 | ||||
| Currency | USD | USD | USD | USD | USD | USD | ||||
| Financial report URL | ||||||||||
| Revenue, bln rub | ? | 11 362 | 11 673 | 12 784 | 15 113 | 14 813 | 14 949 | |||
| Operating Income, bln rub | 976.0 | 603.0 | 779.0 | -549.0 | 390.0 | 129.0 | ||||
| EBITDA, bln rub | ? | 1 765 | 1 426 | 1 669 | 854.0 | 1 751 | 1 174 | |||
| Net profit, bln rub | ? | 1 001 | 1 102 | 1 284 | -2 421 | 2 656 | 2 656 | |||
| OCF, bln rub | ? | 2 104 | 1 868 | 2 222 | 1 211 | 1 726 | 1 726 | |||
| CAPEX, bln rub | ? | 696.0 | 709.0 | 743.0 | 679.0 | 692.0 | 692.0 | |||
| FCF, bln rub | ? | 1 408 | 1 159 | 1 479 | 532.0 | 1 034 | 1 034 | |||
| Dividend payout, bln rub | 423.0 | 473.0 | 530.0 | 573.0 | 586.0 | 586.0 | ||||
| Ordinary share dividend yield, % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | ||||
| Dividend payout ratio, % | 42.3% | 42.9% | 41.3% | 0.00% | 22.1% | 22.1% | ||||
| OPEX, bln rub | 3 885 | 2 971 | 3 395 | 4 528 | 4 563 | 4 565 | ||||
| Cost of production, bln rub | 6 601 | 7 086 | 7 679 | 9 716 | 9 838 | 9 902 | ||||
| R&D, bln rub | 595.0 | 521.0 | 534.0 | 605.0 | 667.0 | 667.0 | ||||
| Interest expenses, bln rub | 111.0 | 134.0 | 192.0 | 395.0 | 512.0 | 494.0 | ||||
| Assets, bln rub | 18 193 | 20 019 | 33 521 | 28 287 | 28 276 | 28 276 | ||||
| Net Assets, bln rub | ? | 7 882 | 8 689 | 9 077 | 5 833 | 8 402 | 8 402 | |||
| Debt, bln rub | 5 961 | 6 804 | 18 310 | 17 213 | 14 364 | 14 364 | ||||
| Cash, bln rub | 3 335 | 3 730 | 2 951 | 1 718 | 3 198 | 3 194 | ||||
| Net debt, bln rub | 2 626 | 3 074 | 15 359 | 15 495 | 11 166 | 11 170 | ||||
| Ordinary share price, rub | 83.6 | 80.2 | 85.8 | 51.0 | 38.7 | 34.2 | ||||
| Number of ordinary shares, mln | 509.0 | 509.0 | 502.0 | 504.0 | 506.0 | 507.0 | ||||
| Market cap, bln rub | 42 563 | 40 842 | 43 092 | 25 689 | 19 562 | 17 339 | ||||
| EV, bln rub | ? | 45 189 | 43 916 | 58 451 | 41 184 | 30 728 | 28 509 | |||
| Book value, bln rub | 3 381 | 3 801 | -8 551 | -7 803 | -4 191 | -4 191 | ||||
| EPS, rub | ? | 1.97 | 2.17 | 2.56 | -4.80 | 5.25 | 5.24 | |||
| FCF/share, rub | 2.77 | 2.28 | 2.95 | 1.06 | 2.04 | 2.04 | ||||
| BV/share, rub | 6.64 | 7.47 | -17.0 | -15.5 | -8.28 | -8.27 | ||||
| EBITDA margin, % | ? | 15.5% | 12.2% | 13.1% | 5.65% | 11.8% | 7.85% | |||
| Net margin, % | ? | 8.81% | 9.44% | 10.0% | -16.0% | 17.9% | 17.8% | |||
| FCF yield, % | ? | 3.31% | 2.84% | 3.43% | 2.07% | 5.29% | 5.96% | |||
| ROE, % | ? | 12.7% | 12.7% | 14.1% | -41.5% | 31.6% | 31.6% | |||
| ROA, % | ? | 5.50% | 5.50% | 3.83% | -8.56% | 9.39% | 9.39% | |||
| P/E | ? | 42.5 | 37.1 | 33.6 | -10.6 | 7.37 | 6.53 | |||
| P/FCF | 30.2 | 35.2 | 29.1 | 48.3 | 18.9 | 16.8 | ||||
| P/S | ? | 3.75 | 3.50 | 3.37 | 1.70 | 1.32 | 1.16 | |||
| P/BV | ? | 12.6 | 10.7 | -5.04 | -3.29 | -4.67 | -4.14 | |||
| EV/EBITDA | ? | 25.6 | 30.8 | 35.0 | 48.2 | 17.5 | 24.3 | |||
| Debt/EBITDA | 1.49 | 2.16 | 9.20 | 18.1 | 6.38 | 9.51 | ||||
| R&D/CAPEX, % | 85.5% | 73.5% | 71.9% | 89.1% | 96.4% | 96.4% | ||||
| CAPEX/Revenue, % | 6.13% | 6.07% | 5.81% | 4.49% | 4.67% | 4.63% | ||||
| Baxter International shareholders | ||||||||||
